NRNP 6665 FINAL EXAM AND NR 603 WEEK 7 – 2026/2027 EXAM PREP QUESTIONS AND ANSWERS
ALREADY GRADED A+| 100% VERIFIED SOLUTIONS
Core Domains
Advanced Psychopharmacology and Neurobiology
Psychiatric Assessment and Differential Diagnosis
Management of Complex Psychiatric Disorders
Pharmacokinetics and Pharmacodynamics in Mental Health
Adverse Drug Reactions and Drug Interactions
Child, Adolescent, and Geriatric Psychiatry
Substance Use and Co-occurring Disorders
Ethical and Legal Issues in Psychiatric Practice
Psychotherapy and Integrated Treatment Modalities
Clinical Decision-Making and Evidence-Based Practice
Introduction
This comprehensive examination is designed to prepare candidates for the NRNP 6665 Final Exam and NR 603
Week 7 assessment, focusing on advanced psychiatric-mental health nursing practice. The exam evaluates clinical
knowledge, diagnostic reasoning, and pharmacotherapeutic decision-making in the management of complex
psychiatric disorders across the lifespan. Candidates will be challenged with multiple-choice and scenario-based
,questions that emphasize real-world clinical application, critical thinking, and the integration of neurobiological
principles with evidence-based treatment guidelines. This assessment serves as a vital tool for identifying strengths
and areas for focused review prior to the certification examination.
SECTION ONE: QUESTIONS 1–100
1. A 45-year-old male with a history of major depressive disorder presents with a two-week history of
depressed mood, anhedonia, fatigue, and insomnia. He has been on sertraline 50 mg daily for 6 weeks with
minimal improvement. Which of the following is the most appropriate next step in management?
A. Increase sertraline to 100 mg daily.
B. Add bupropion 150 mg daily.
C. Switch to fluoxetine 20 mg daily.
D. Add aripiprazole 2 mg daily.
🟢A
🔴 RATIONALE: The patient has had an inadequate response to sertraline at the starting dose. The first step is
to titrate the SSRI to a therapeutic dose (e.g., sertraline 100-200 mg daily) before considering augmentation or
switching. Adding bupropion or aripiprazole would be considered after optimizing the SSRI dose. Switching to
another SSRI is a later step.
,2. A 32-year-old female presents with a complaint of persistent auditory hallucinations and disorganized
speech. She reports that her family has noticed that she has been acting strangely and has withdrawn from
social activities. She has no history of substance use. Which of the following is the most appropriate initial
pharmacological treatment?
A. Aripiprazole 10 mg daily
B. Olanzapine 10 mg daily
C. Risperidone 2 mg daily
D. Haloperidol 5 mg daily
🟢C
🔴 RATIONALE: The patient has schizophrenia. Atypical antipsychotics are the first-line treatment. Risperidone
is a commonly used atypical antipsychotic with established efficacy. Aripiprazole and olanzapine are also first-
line options but may have different side effect profiles. Haloperidol is a typical antipsychotic and is not first-line
due to a higher risk of extrapyramidal symptoms.
3. A 28-year-old female with bipolar I disorder presents with a sudden onset of elevated mood, decreased
need for sleep, grandiosity, and increased goal-directed activity. She reports that she has been spending
excessive amounts of money and has been unusually productive at work. Which of the following is the most
appropriate initial pharmacologic intervention for acute mania?
A. Lithium 300 mg three times daily
B. Valproic acid 250 mg three times daily
, C. Olanzapine 10 mg daily
D. Lamotrigine 25 mg daily
🟢C
🔴 RATIONALE: For acute mania, atypical antipsychotics (e.g., olanzapine, risperidone, quetiapine) are first-line
agents due to their rapid onset of action. Lithium and valproic acid are effective but have a slower onset.
Lamotrigine is not effective for acute mania and is used for maintenance therapy.
4. A 65-year-old male with a history of generalized anxiety disorder is prescribed buspirone. Which of the
following is the most important counseling point regarding this medication?
A. Full therapeutic effect may take 2-4 weeks.
B. It should be used on an as-needed basis for acute anxiety.
C. It has a high potential for dependence.
D. It causes significant sedation.
🟢A
🔴 RATIONALE: Buspirone is a non-benzodiazepine anxiolytic with a delayed onset of action (2-4 weeks) for full
therapeutic effect. It is not effective for acute anxiety and has a low potential for dependence. It is not
significantly sedating.
ALREADY GRADED A+| 100% VERIFIED SOLUTIONS
Core Domains
Advanced Psychopharmacology and Neurobiology
Psychiatric Assessment and Differential Diagnosis
Management of Complex Psychiatric Disorders
Pharmacokinetics and Pharmacodynamics in Mental Health
Adverse Drug Reactions and Drug Interactions
Child, Adolescent, and Geriatric Psychiatry
Substance Use and Co-occurring Disorders
Ethical and Legal Issues in Psychiatric Practice
Psychotherapy and Integrated Treatment Modalities
Clinical Decision-Making and Evidence-Based Practice
Introduction
This comprehensive examination is designed to prepare candidates for the NRNP 6665 Final Exam and NR 603
Week 7 assessment, focusing on advanced psychiatric-mental health nursing practice. The exam evaluates clinical
knowledge, diagnostic reasoning, and pharmacotherapeutic decision-making in the management of complex
psychiatric disorders across the lifespan. Candidates will be challenged with multiple-choice and scenario-based
,questions that emphasize real-world clinical application, critical thinking, and the integration of neurobiological
principles with evidence-based treatment guidelines. This assessment serves as a vital tool for identifying strengths
and areas for focused review prior to the certification examination.
SECTION ONE: QUESTIONS 1–100
1. A 45-year-old male with a history of major depressive disorder presents with a two-week history of
depressed mood, anhedonia, fatigue, and insomnia. He has been on sertraline 50 mg daily for 6 weeks with
minimal improvement. Which of the following is the most appropriate next step in management?
A. Increase sertraline to 100 mg daily.
B. Add bupropion 150 mg daily.
C. Switch to fluoxetine 20 mg daily.
D. Add aripiprazole 2 mg daily.
🟢A
🔴 RATIONALE: The patient has had an inadequate response to sertraline at the starting dose. The first step is
to titrate the SSRI to a therapeutic dose (e.g., sertraline 100-200 mg daily) before considering augmentation or
switching. Adding bupropion or aripiprazole would be considered after optimizing the SSRI dose. Switching to
another SSRI is a later step.
,2. A 32-year-old female presents with a complaint of persistent auditory hallucinations and disorganized
speech. She reports that her family has noticed that she has been acting strangely and has withdrawn from
social activities. She has no history of substance use. Which of the following is the most appropriate initial
pharmacological treatment?
A. Aripiprazole 10 mg daily
B. Olanzapine 10 mg daily
C. Risperidone 2 mg daily
D. Haloperidol 5 mg daily
🟢C
🔴 RATIONALE: The patient has schizophrenia. Atypical antipsychotics are the first-line treatment. Risperidone
is a commonly used atypical antipsychotic with established efficacy. Aripiprazole and olanzapine are also first-
line options but may have different side effect profiles. Haloperidol is a typical antipsychotic and is not first-line
due to a higher risk of extrapyramidal symptoms.
3. A 28-year-old female with bipolar I disorder presents with a sudden onset of elevated mood, decreased
need for sleep, grandiosity, and increased goal-directed activity. She reports that she has been spending
excessive amounts of money and has been unusually productive at work. Which of the following is the most
appropriate initial pharmacologic intervention for acute mania?
A. Lithium 300 mg three times daily
B. Valproic acid 250 mg three times daily
, C. Olanzapine 10 mg daily
D. Lamotrigine 25 mg daily
🟢C
🔴 RATIONALE: For acute mania, atypical antipsychotics (e.g., olanzapine, risperidone, quetiapine) are first-line
agents due to their rapid onset of action. Lithium and valproic acid are effective but have a slower onset.
Lamotrigine is not effective for acute mania and is used for maintenance therapy.
4. A 65-year-old male with a history of generalized anxiety disorder is prescribed buspirone. Which of the
following is the most important counseling point regarding this medication?
A. Full therapeutic effect may take 2-4 weeks.
B. It should be used on an as-needed basis for acute anxiety.
C. It has a high potential for dependence.
D. It causes significant sedation.
🟢A
🔴 RATIONALE: Buspirone is a non-benzodiazepine anxiolytic with a delayed onset of action (2-4 weeks) for full
therapeutic effect. It is not effective for acute anxiety and has a low potential for dependence. It is not
significantly sedating.
